<DOC>
	<DOCNO>NCT02338544</DOCNO>
	<brief_summary>The purpose observational trial ass application convenience Epiduo® PUMP daily clinical practice condition patient moderate severe inflammatory acne .</brief_summary>
	<brief_title>Application Epiduo ( R ) PUMP Daily Practice Patients With Inflammatory Acne</brief_title>
	<detailed_description>The objective observational trial ass application convenience Epiduo® PUMP daily clinical practice condition patient moderate severe inflammatory acne use drug topical monotherapy combination drug . In addition , efficacy Epiduo® incidence adverse event assess marketed condition . Also , patient ' body belief record use dysmorphic concern questionnaire . The observational study design multicentre study , cover part Germany . Participating investigator dermatologist adequate patient pool acne patient . The observation time per patient 3 month .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Age ≥9 year The patient diagnose moderate severe inflammatory acne ( Leeds Grade 412 ) Chest/back affect allow , required Topical therapy acne Epiduo® indicate , decision treat patient Epiduo® make independently study Pregnancy breastfeed Acne inversa Acne preferential manisfestation microcysts , macrocysts macrocomedones Hypersensitivity medication ingredients Other contraindication mention Epiduo® SPC</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>